Brief: Qlife Says Application For Placing Co's Covid-19 Test On Market Prior To CE-Marking Received Preliminary Rejection By Danish Medicines Agency
Nov 13 (Reuters) - Qlife Holding AB QLIFE.ST :
* APPLICATION FOR PLACING CO'S COVID-19 TEST ON MARKET PRIOR
TO
CE-MARKING RECEIVED A PRELIMINARY REJECTION BY DANISH MEDICINES
AGENCY
* QLIFE NOW HAS 14 DAYS TO RESPOND TO PRELIMINARY
ANNOUNCEMENT
* QLIFE - WILL NOW EVALUATE TODAY'S DECISION & HOW TO
PROCEED WITH
CURRENT APPLICATION ALONG WITH PARALLEL PROCESS TOWARDS CE
APPROVAL FOR COVID-19 TEST
Source text for Eikon: ID:nWkr9MfLx3
Further company coverage: QLIFE.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Qlife Holding AB
See all newsAdvisory: Alerts on Qlife's agreement with global pharma company withdrawn
Brief: Qlife Holding Enters Feasibility Deal With Pharma Co For Egoo Health Biomarker
Brief: Qlife Holding Q1 EBITDA Loss SEK 5.5 Mln
Sweden's Qlife Q1 revenue drops, losses widen slightly
Brief: Qlife Holding Q4 EBITDA At SEK -1.6 Million